Doxorubicin liposomal Interactions
There are 604 drugs known to interact with doxorubicin liposomal, along with 4 disease interactions. Of the total drug interactions, 112 are major, 464 are moderate, and 28 are minor.
- View all 604 medications that may interact with doxorubicin liposomal
- View doxorubicin liposomal disease interactions (4)
Most frequently checked interactions
View interaction reports for doxorubicin liposomal and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Abraxane (paclitaxel protein-bound)
- Aceta (acetaminophen)
- Acetylsalicylic Acid (aspirin)
- Adderall (amphetamine / dextroamphetamine)
- Adriamycin (doxorubicin)
- Akynzeo (netupitant / palonosetron)
- Albuminar-25 (albumin human)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aldactone (spironolactone)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Avastin (bevacizumab)
- CoQ10 (ubiquinone)
- Curcumin 95 (turmeric)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Gemzar (gemcitabine)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Neulasta (pegfilgrastim)
- Paracetamol (acetaminophen)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Quercetin (bioflavonoids)
- Synthroid (levothyroxine)
- Taxotere (docetaxel)
- Tramadol Hydrochloride ER (tramadol)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Doxorubicin liposomal disease interactions
There are 4 disease interactions with doxorubicin liposomal which include:
Report options
More about doxorubicin liposomal
- doxorubicin liposomal consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antibiotics/antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Paclitaxel
Paclitaxel systemic is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.